anti-MHC-bound peptide antibodies (Immatics/MorphoSys)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-MHC-bound peptide antibodies (Immatics/MorphoSys)
Drug Alias Nameanti-MHC-bound peptides antibodies (Immatics and MorphoSys)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionHuman leukocyte antigen inhibitors
TargetsHuman leukocyte antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMorphosys Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMorphosys AgImmatics NV
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A